Flow of payments for 3,000 USD HIV medication with patient coinsurance U.S. 2017

Flow of payments for a 3,000 dollar HIV medication if the patient pays coinsurance in the U.S. as of 2017*

by Matej Mikulic, last edited May 23, 2018
Flow of payments for 3,000 USD HIV medication with patient coinsurance U.S. 2017 This statistic shows the flow of payments in the United States for a hypothetical HIV medication that costs 3,000 U.S. dollars while the patient has commercial coverage that requires to pay a coinsurance of 20 percent, as of 2017. According to the model, the manufacturer retains 1,905 U.S. dollars while the health insurance plan/ plan sponsor spends 1,830.25 dollars.
Show more

Flow of payments for a 3,000 dollar HIV medication if the patient pays coinsurance in the U.S. as of 2017*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "HIV/AIDS in the U.S."
  • Global context
The most important statistics
  • HIV testing
  • HIV prevalence
  • AIDS diagnoses
  • Death rates
  • Risk factors
  • U.S. states
  • Miscellaneous
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.